Form 4: Organogenesis Holdings Inc. Executive Brian Grow Reports Stock and Option Awards

Chief Commercial Officer Brian Grow of Organogenesis Holdings Inc. reports the acquisition of restricted stock units and stock options.

Summary

• Brian Grow, Chief Commercial Officer of Organogenesis Holdings Inc., filed a Form 4.
• The filing reports the grant of 183,067 restricted stock units (RSUs) and an option to purchase 189,369 shares of Class A Common Stock on February 19, 2025.
• The RSUs vest in equal annual installments over four years beginning February 15, 2025.
• The stock options, with an exercise price of $3.53, also become exercisable in equal annual installments over four years beginning February 15, 2025.
• Following the reported transactions, Grow beneficially owns 670,490 shares of Class A Common Stock and 189,369 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option grants, which is neither particularly positive nor negative on its own.

Positives

• The grant of RSUs and stock options to a key executive like the Chief Commercial Officer suggests an incentive alignment with the company's long-term performance.
• The vesting schedule encourages continued service and contribution from the executive over the next four years.

Future Outlook

The vesting schedule of the RSUs and stock options indicates a four-year horizon for incentivizing the executive's performance.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in the company's securities. This filing is typical for executives receiving equity-based compensation.

Stakeholder Impact

• The equity grants could potentially dilute existing shareholders, although the impact is likely to be minimal.
• The grants incentivize the Chief Commercial Officer, which could benefit shareholders if it leads to improved company performance.

Key Dates

Keywords

Form 4, Organogenesis Holdings Inc., Brian Grow, Chief Commercial Officer, Stock Options, Restricted Stock Units, Equity Incentive Plan, Beneficial Ownership